|
|
||
|
|
The Cardiovascular Division at University of Louisville School of Medicine is dedicated to providing exceptional and compassionate care to patients, and leading the field in basic and clinical cardiovascular research. Most importantly we are dedicated to shaping the minds of future generations of leaders in cardiovascular medicine. The The PARTNER II clinical trial using a nonsurgical transcatheter approach to aortic valve replacement comes to UofL and Jewish Hospital with Dr. Michael Flaherty as the Co-principal investigator. UofL becomes part of new multicenter stem cell trial implanting circulating CD34+ progenitor cells in patient with refractory angina with Drs Roberto Bolli and Michael Flaherty as principal investigators. Read more
|
|



